GeneDx Holdings Corp. (WGSWW)

Market Cap	2.68B
Revenue (ttm)	305.45M
Net Income (ttm)	-52.29M
Shares Out	28.07M
EPS (ttm)	-1.94
PE Ratio	n/a
Forward PE	105.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,501
Open	0.1800
Previous Close	0.1743
Day's Range	0.1800 - 0.1800
52-Week Range	0.1401 - 0.1743
Beta	2.00
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 18, 2025

About WGSWW

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2017
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WGSWW
• Website: https://www.genedx.com

Financial Performance

In 2024, GeneDx Holdings's revenue was $305.45 million, an increase of 50.79% compared to the previous year's $202.57 million. Losses were -$52.29 million, -70.25% less than in 2023.